Feb. 10, 2023
Jury awards heart valve maker $106.5M, appeal promised
Medtronic CoreValve contends that the invention that is claimed in the ’ patent was not new or was obvious and is therefore invalid. The jury unanimously voted that Medtronic actively induced infringement of heart valves patented by Colibri.




A cardiac valve manufacturer won a $106.5 million jury verdict against its competitor for patent infringement after a weeklong trial in federal court in Santa Ana.
The defendant, Medtronic, represented by Kathryn B. Riley and Mark D. Fowler at DLA Piper, has not admitted any liability and intends to appeal the verdict.
“The verdict is a validation of the significant contribution the Colibri inventors made to the...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In